Maxcyte, Inc. SEC filings MXCT

Maxcyte, Inc. has 336 filings in SEC EDGAR's recent list, going back to Apr 14, 2004. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (results of operations). The company's fiscal year ends on December 31.

Maxcyte, Inc. SEC filings
Form Description Filed Period
EFFECT Filing Jul 29, 2021 —
CERT Filing Jul 29, 2021 —
CORRESP Letter to the SEC Jul 27, 2021 —
CORRESP Letter to the SEC Jul 27, 2021 —
8-A12B Filing Jul 27, 2021 —
CORRESP Letter to the SEC Jul 9, 2021 —
UPLOAD Letter from the SEC Jul 8, 2021 —
DRSLTR Filing Jun 25, 2021 —
DRS/A Filing Jun 25, 2021 —
UPLOAD Letter from the SEC Jun 10, 2021 —
DRS Filing May 14, 2021 —
D Filing Sep 29, 2016 —
D Filing Dec 16, 2014 —
D/A Filing Oct 13, 2009 —
D Filing Aug 31, 2009 —
REGDEX Auto-generated paper document Sep 18, 2008 —
REGDEX/A Auto-generated paper document Oct 30, 2007 —
REGDEX/A Auto-generated paper document Oct 10, 2006 —
REGDEX Auto-generated paper document Apr 25, 2006 —
REGDEX Auto-generated paper document Apr 28, 2005 —
REGDEX Auto-generated paper document Apr 14, 2004 —

Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
MXCT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Rockville, MD
SEC filer status
, Emerging growth company
SEC CIK
1287098
Former names
MAXCYTE INC (until Sep 18, 2008)

Other Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.